...
机译:用2-(4-(吡啶-2-基)苯氧基)吡啶类似物的晚期官能化辅助p-糖蛋白介导的多药耐热抑制剂的有效抑制剂的发现
Chinese Acad Med Sci &
Peking Union Med Coll Inst Mat Med Beijing 100050 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
St Johns Univ Coll Pharm &
Hlth Sci New York NY 11439 USA;
St Johns Univ Coll Pharm &
Hlth Sci New York NY 11439 USA;
Chinese Acad Med Sci &
Peking Union Med Coll Inst Mat Med Beijing 100050 Peoples R China;
China Pharmaceut Univ Ctr Drug Discovery State Key Lab Nat Med Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Drug Discovery State Key Lab Nat Med Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Drug Discovery State Key Lab Nat Med Nanjing 210009 Peoples R China;
China Pharmaceut Univ Ctr Drug Discovery State Key Lab Nat Med Nanjing 210009 Peoples R China;
Tsinghua Univ Sch Pharmaceut Sci Beijing 100084 Peoples R China;
机译:用2-(4-(吡啶-2-基)苯氧基)吡啶类似物的晚期官能化辅助p-糖蛋白介导的多药耐热抑制剂的有效抑制剂的发现
机译:发现4- {4- [3-(吡啶-2-基)-1H-吡唑-4-基]吡啶-2-基} -N-(四氢-2H-吡喃-4-基)苯甲酰胺(GW788388) :一种有力,选择性和口服活性转化生长因子βI型受体抑制剂
机译:效力激酶抑制剂BMS-986236的可扩展合成的研制; 1-(5-(3-羟基-3-甲基丁基)-1H-1,2,3-三唑-1-基)-4-(异丙基氨基)吡啶-2-基)-1H-吡唑唑[3 ,4-B]吡啶-5-碳腈
机译:(4-(2 - ((5-羟基-1234-四氢萘-2-基)(丙基)氨基) - 乙基)哌嗪-1-基)-4-喹啉发现-8-醇及其类似物作为高度有效的多巴胺D2 / D3激动剂和作为铁螯合剂:在体内活性指示用于帕金森氏病症状的神经保护和治疗的潜在应用
机译:发现羟丙蛋白介导的多药耐热耐热抑制剂的辅助阶段官能化的多药抑制剂(4-(吡啶-2-基)苯氧基)吡啶类似物
机译:发现有效抑制剂对乳腺癌多药耐药性的影响